18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-OCS-13003773
正在进行
/
/
/
2013-11-11
/
/
Valvular Heart Disease
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
单臂
其它
NA
/
Division of Cardiology, Department of Medicine and Therapeutics
/
300
/
2013-11-06
1990-01-01
/
a) Patients with significant MR or AS (≥mild); b) Patients with organic MR or AS; c) Patients able to undergo a comprehensive echocardiographic evaluation; d) The patient or the guardian gives written informed consent before participating the study; e) The patient is willing to give full information on his/her medical history, including the drugs.;
登录查看a) Patient with functional (for example, ischemic MR) MR; b) Patient with concomitant valvular heart disease other than MR or AS; c) Patient with other concomitant congenital heart disease.;
登录查看NO
/
药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24